BACKGROUND: Influenza causes significant morbidity and mortality, with considerable economic costs, including lost work productivity. Influenza vaccines may reduce the economic burden through primary prevention of influenza and reduction in illness severity. METHODS: We examined illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses and compared outcomes for subjects with and without laboratory-confirmed influenza and by influenza vaccination status among subjects with influenza during the 2012-2013 influenza season. RESULTS: Illnesses laboratory-confirmed as influenza (ie, cases) were subjectively assessed as more severe than illnesses not caused by influenza (ie, noncases) based on multiple measures, including current health status at study enrollment (≤7 days from illness onset) and current activity and sleep quality status relative to usual. Influenza cases reported missing 45% more work hours (20.5 vs 15.0; P < .001) than noncases and subjectively assessed their work productivity as impeded to a greater degree (6.0 vs 5.4; P < .001). Current health status and current activity relative to usual were subjectively assessed as modestly but significantly better for vaccinated cases compared with unvaccinated cases; however, no significant modifications of sleep quality, missed work hours, or work productivity loss were noted for vaccinated subjects. CONCLUSIONS: Influenza illnesses were more severe and resulted in more missed work hours and productivity loss than illnesses not confirmed as influenza. Modest reductions in illness severity for vaccinated cases were observed. These findings highlight the burden of influenza illnesses and illustrate the importance of laboratory confirmation of influenza outcomes in evaluations of vaccine effectiveness.
BACKGROUND: Influenza causes significant morbidity and mortality, with considerable economic costs, including lost work productivity. Influenza vaccines may reduce the economic burden through primary prevention of influenza and reduction in illness severity. METHODS: We examined illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses and compared outcomes for subjects with and without laboratory-confirmed influenza and by influenza vaccination status among subjects with influenza during the 2012-2013 influenza season. RESULTS: Illnesses laboratory-confirmed as influenza (ie, cases) were subjectively assessed as more severe than illnesses not caused by influenza (ie, noncases) based on multiple measures, including current health status at study enrollment (≤7 days from illness onset) and current activity and sleep quality status relative to usual. Influenza cases reported missing 45% more work hours (20.5 vs 15.0; P < .001) than noncases and subjectively assessed their work productivity as impeded to a greater degree (6.0 vs 5.4; P < .001). Current health status and current activity relative to usual were subjectively assessed as modestly but significantly better for vaccinated cases compared with unvaccinated cases; however, no significant modifications of sleep quality, missed work hours, or work productivity loss were noted for vaccinated subjects. CONCLUSIONS: Influenza illnesses were more severe and resulted in more missed work hours and productivity loss than illnesses not confirmed as influenza. Modest reductions in illness severity for vaccinated cases were observed. These findings highlight the burden of influenza illnesses and illustrate the importance of laboratory confirmation of influenza outcomes in evaluations of vaccine effectiveness.
Authors: Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges Journal: Vaccine Date: 2007-04-20 Impact factor: 3.641
Authors: William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda Journal: JAMA Date: 2004-09-15 Impact factor: 56.272
Authors: Ashley Fowlkes; Andrea Giorgi; Dean Erdman; Jon Temte; Kate Goodin; Steve Di Lonardo; Yumei Sun; Karen Martin; Michelle Feist; Rachel Linz; Rachelle Boulton; Elizabeth Bancroft; Lisa McHugh; Jose Lojo; Kimberly Filbert; Lyn Finelli Journal: J Infect Dis Date: 2013-12-12 Impact factor: 5.226
Authors: Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Suzana Sabaiduc; Alireza Eshaghi; James A Dickinson; Kevin Fonseca; Anne-Luise Winter; Jonathan B Gubbay; Mel Krajden; Martin Petric; Hugues Charest; Nathalie Bastien; Trijntje L Kwindt; Salaheddin M Mahmud; Paul Van Caeseele; Yan Li Journal: PLoS One Date: 2014-03-25 Impact factor: 3.240
Authors: Ryan E Malosh; Emily T Martin; Amy P Callear; Joshua G Petrie; Adam S Lauring; Lois Lamerato; Alicia M Fry; Jill Ferdinands; Brendan Flannery; Arnold S Monto Journal: J Clin Virol Date: 2017-09-07 Impact factor: 3.168
Authors: Ana E Gamiño-Arroyo; M Lourdes Guerrero; Sean McCarthy; Alejandra Ramírez-Venegas; Beatriz Llamosas-Gallardo; Arturo Galindo-Fraga; Sarbelio Moreno-Espinosa; Yuri Roldán-Aragón; Javier Araujo-Meléndez; Sally Hunsberger; Violeta Ibarra-González; Julia Martínez-López; Luis A García-Andrade; Heather Kapushoc; H Preston Holley; Mary C Smolskis; Guillermo M Ruiz-Palacios; John H Beigel Journal: Clin Infect Dis Date: 2019-11-13 Impact factor: 9.079
Authors: Pranab K Mukherjee; Frank Esper; Ken Buchheit; Karen Arters; Ina Adkins; Mahmoud A Ghannoum; Robert A Salata Journal: BMC Infect Dis Date: 2017-01-14 Impact factor: 3.090
Authors: L Coughlan; S Sridhar; R Payne; M Edmans; A Milicic; N Venkatraman; B Lugonja; L Clifton; C Qi; P M Folegatti; A M Lawrie; R Roberts; H de Graaf; P Sukhtankar; S N Faust; D J M Lewis; T Lambe; Avs Hill; S C Gilbert Journal: EBioMedicine Date: 2018-02-15 Impact factor: 8.143
Authors: Narges Moghimi; Mario Di Napoli; José Biller; James E Siegler; Rahul Shekhar; Louise D McCullough; Michelle S Harkins; Emily Hong; Danielle A Alaouieh; Gelsomina Mansueto; Afshin A Divani Journal: Curr Neurol Neurosci Rep Date: 2021-06-28 Impact factor: 5.081
Authors: Michael A Estrin; Islam T M Hussein; Wendy B Puryear; Anne C Kuan; Stephen C Artim; Jonathan A Runstadler Journal: PLoS One Date: 2018-05-18 Impact factor: 3.240
Authors: Mark W Tenforde; Sara S Kim; Christopher J Lindsell; Erica Billig Rose; Nathan I Shapiro; D Clark Files; Kevin W Gibbs; Heidi L Erickson; Jay S Steingrub; Howard A Smithline; Michelle N Gong; Michael S Aboodi; Matthew C Exline; Daniel J Henning; Jennifer G Wilson; Akram Khan; Nida Qadir; Samuel M Brown; Ithan D Peltan; Todd W Rice; David N Hager; Adit A Ginde; William B Stubblefield; Manish M Patel; Wesley H Self; Leora R Feldstein Journal: MMWR Morb Mortal Wkly Rep Date: 2020-07-31 Impact factor: 17.586